Skip to content

Comparison of Diagnostic Efficacy Between a Novel Portable Sleep Monitoring Device and Polysomnography in Obstructive Sleep Apnea: A Multicenter, Prospective Study

Comparison of Diagnostic Efficacy Between a Novel Portable Sleep Monitoring Device and Polysomnography in Obstructive Sleep Apnea: A Multicenter, Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125647
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Interventions

Gold Standard:The gold standard for the diagnosis of obstructive sleep apnea (OSA) is polysomnography (PSG), which mainly collects parameters such as electroencephalogram (EEG), electrooculogram (EOG)
- Awakening from sleep with choking, gasping, or a feeling of suffocation
- Bed partners observe habitual snoring, breathing pauses, or both
- Complicated with hypertension, mood disorders, cognitive impairment, coronary heart disease, stroke, heart failure, atrial fibrillation, or type 2 diabetes. 2. PSG shows: - 5 or more obstructive-do
Index test:To evaluate the diagnostic accuracy of a novel sleep monitoring device for OSA using PSG as the gold standard Methods: A multicenter prospective study Device: DM-AS03 sleep monitoring mattr

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Signed an informed consent form before participating in the study and was able to participate in the study in accordance with the protocol. 2.Patients with specific diseases included those with hypertension, coronary heart disease, stroke, chronic obstructive pulmonary disease (COPD), asthma, etc. 3.Clear consciousness, good communication ability, and able to cooperate with the questionnaire survey.

Exclusion criteria

Exclusion criteria: 1.Patients with severe mental and psychological diseases; 2.Populations who need long-term bed rest or have limited mobility and cannot go to the sleep center; 3.Patients with severe organ failure; 4.Patients with severe diseases, acute infections, or those requiring oxygen therapy; 5.In polysomnography (PSG), the total recorded sleep time is < 240 minutes; 6.Incomplete answers to the scales;

Design outcomes

Primary

MeasureTime frame
Apnea-Hypopnea Index (AHI);Oxygen Desaturation Index (ODI);Lowest oxygen saturation;Time at SpO? < 90%;Total Sleep Time;Immobility time;Postural events;AUC value under the ROC curve;Sensitivity;Specificity;Positive Predictive Value(PPV);Negative Predictive Value(NPV);Accuracy;

Secondary

MeasureTime frame
neck circumference;waist circumference;hip circumference;Mallampati score;tonsillar hypertrophy;mandibular retrognathia;macroglossia;demographic characteristics;OSA-related clinical symptoms;comorbidities;previous history and treatment of OSA;Epworth Sleepiness Scale;Pittsburgh Sleep Quality Index;Insomnia Severity Index (ISI);Comfort and satisfaction of subjects with different monitoring devices;

Countries

China

Contacts

Public ContactZhang Nuofu

The First Affiliated Hospital of Guangzhou Medical University

nfzhanggird@163.com+86 136 0046 0056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026